Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Recall
Sort By
Newest First
1 / 1
1 / 1
Recall
Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride
Teva Pharmaceutical Industries
PR-M06-20-NI-025-1496
Jun 18, 2020
Recall
Takeda Issues US Recall of Two Lots of VONVENDI
Takeda
PR-M02-20-NI-038
Feb 27, 2020
Recall
FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)
U.S. Food & Drug Administration
PR-M10-19-NI-047
Oct 30, 2019
Recall
Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets
U.S. Food & Drug Administration
PR-M09-19-NI-055
Sep 27, 2019
Recall
FDA Announces Voluntary Recall of Sandoz Ranitidine Capsules Following Detection of an Impurity
U.S. Food & Drug Administration
PR-M09-19-NI-049
Sep 24, 2019
Recall
Pacifico National, Inc. dba AmEx Pharmacy Issues Voluntary Nationwide Recall for all Lots of Bevacizumab
U.S. Food & Drug Administration
PA2164
Sep 05, 2019
Recall
Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® Due to Potential Microbiological Contamination of Non-Sterile Product
Pfizer
PR-M08-19-NI-048
Aug 16, 2019
Recall
FDA Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from Market
U.S. Food & Drug Administration
PR-M07-19-NI-071
Jul 26, 2019
Recall
Bayer Statement on Voluntary Recall of Two Lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States
Nice Insight
PR-M07-19-NI-062
Jul 24, 2019
Recall
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products
Nice Insight
PR-M07-19-NI-036
Jul 15, 2019
Recall
Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter
Mylan
PR-M03-19-NI-050
Mar 19, 2019
Drug Recall
FDA Provides Update on its Ongoing Investigation into ARB Drug Products and Losartan Product Recall
U.S. Food & Drug Administration
PR-M03-19-NI-001
Mar 01, 2019
Recall
Mylan Initiates Voluntary Nationwide Recall Due to the Detection of Trace Amounts of NDEA
Mylan
PR-M11-18-NI-087
Nov 26, 2018
Recall
Sandoz Issues Voluntary Recall of Losartan
Nice Insight
PAO-M11-18-NI-016
Nov 20, 2018
Pediatric
Incorrect Dosing Cup Leads to Recall of Children’s Advil Suspension
Nice Insight
PAO-M09-18-NI-005
Sep 06, 2018